378
Views
7
CrossRef citations to date
0
Altmetric
Review

Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria

, , , &
Pages 983-991 | Received 07 Jul 2020, Accepted 07 Jan 2021, Published online: 17 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Russo, Paolo Fusco, Helen Linda Morrone, Enrico Maria Trecarichi & Carlo Torti. (2023) New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Review of Anti-infective Therapy 21:1, pages 41-55.
Read now

Articles from other publishers (6)

G. Lombardi, E.S. Tanzarella, S.L. Cutuli & G. De Pascale. (2023) Treatment of severe infections caused by ESBL or carbapenemases-producing Enterobacteriaceae. Medicina Intensiva (English Edition) 47:1, pages 34-44.
Crossref
G. Lombardi, E.S. Tanzarella, S.L. Cutuli & G. De Pascale. (2023) Treatment of severe infections caused by ESBL or carbapenemases-producing Enterobacteriaceae. Medicina Intensiva 47:1, pages 34-44.
Crossref
Almudena Burillo & Emilio Bouza. (2022) Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales: what questions remain for future studies?. Current Opinion in Infectious Diseases 35:6, pages 575-582.
Crossref
Alessandro Russo, Antonio Vena & Matteo Bassetti. (2022) Antibiotic treatment of acute bacterial skin and skin structure infections. Current Opinion in Infectious Diseases 35:2, pages 120-127.
Crossref
Alessandro Russo, Enrico Maria Trecarichi & Carlo Torti. (2022) The role of Gram-negative bacteria in skin and soft tissue infections. Current Opinion in Infectious Diseases 35:2, pages 95-102.
Crossref
Alessandro Russo, David L. Paterson & Matteo Bassetti. (2021) Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to Therapy. Frontiers in Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.